Improving survival of stage II‐III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy

BACKGROUND: There is no consistent evidence about the appropriate treatment strategies for gastric signet ring cell carcinoma (GSRC) to improve prognosis. We conducted a population‐based study to examine the effects of combined modality therapies on survival outcomes using the Surveillance, Epidemio...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Med
Main Authors: Li, Yang, Zhu, Zhikai, Ma, Fuhai, Xue, Liyan, Tian, Yantao
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2020
Subjects:
Clinical Cancer Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7520351/
https://ncbi.nlm.nih.gov/pubmed/32744431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3342
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items